We and others previously found divergent regional patterns of microscopic GM pathology across hemispheres in FTLD-Tau compared to FTLD-TDP with clinical PPA [18, 44], suggesting that these specific proteinopathies have distinct patterns of cellular degeneration, which may influence the regional patterns of disease in cognitive networks to yield somewhat different clinical phenotypes. This evidence concerns the gene MAPT and proteostasis deficiencies.